Here at Drug Discovery World (DDW) we've been publishing articles written by leading experts in the Drug Discovery, Pharmaceutical, and BioPharmaceutical industries for over 20 years.
DDW has grown as a quarterly business review of drug discovery and development, and now we've created this podcast to allow you to listen to our articles on the go.
In our journal and this podcast, we cover topics surrounding: drug discovery; drug development; business; chemistry; enabling technologies; informatics; personalised medicine; screening; therapeutics, and much more.
For the podcast we have selected recent, relevant and popular scientific articles, so that you can listen to all of the best content from Drug Discovery World. We hope you enjoy.
Building on current drug discovery methods
In the first article, the authors explore applications of synthetic DNA in drug discovery and development, the benefits and limitations of current methods, and the opportunities offered by emerging DNA synthesis technologies.
In the wake of Covid-19 interest in repurposing a drug for a different indication to the one it was developed for has been high. In the second article, the authors offer insight into the process.
Analysing the technology driving innovation in drug discovery
In the first article, DDW Editor Lu Rahman takes look at some of the latest imaging innovations available and how it can benefit drug target identification and drug discovery research.
In the second, Farah Patell-Socha, PhD, VP Research Products tells Lu Rahman about some of the company’s groundbreaking work in this field and the benefits it is creating for disease modelling and drug discovery.
The important role that antibodies play in drug discovery
Sophie Lutter, OXGENE, looks at the important role antibody therapeutics have to play and how, as the world has looked for Covid-19 treatments in the last year, their significance has been noted.
Toni Rogers and David Bunka, Aptamer Group discuss how newer antibody alternative technologies are demonstrating significant developments, offering novel solutions to improve success, decrease project timelines and produce innovative low-cost assays to small molecule targets across many sectors.
Enhancing the role of multiplexing in high-throughput screening
The latest sponsored DDW Sitting Down With podcast features Paul Wylie, Director of Multiplex at Abcam looking at enhancing the role of multiplexing in high-throughput screening.
Among the topics Lu Rahman will be discussing with Wylie will be the key challenges scientists face with biomarker and drug discovery and how high-throughput screening can help alleviate this.
Listen now to find out more.
The Bamlanivimab story - how it reached clinic in eight months
The latest DDW Sitting Down With podcast features Bryan Jones, Senior Research Fellow, BioTechnology Discovery Research, Eli Lilly and Co and Dan Bedinger, Application Science Team Lead, Carterra.
Jones and Bedinger talk us through the Bamlanivimab story – and how one technology enabled this therapeutic to reach clinic in eight months during the pandemic.
Recipe for success: collaboration in drug discovery
The latest free-to-listen DDW podcast episode is titled “Recipe for success: collaboration in drug discovery”.
It covers three articles: “Why collaboration matters and how to make it a success”; “Platform biotechnologies and the art of collaboration”; and “Cell painting: a vibrant future for phenotypic drug discovery”.
Really informative scientific podcast
Perfect for a variety of topics around drug discovery
A really thorough informative podcast with a variation of information around drug discovery and pharma